Merck KGaA. Dermapharm Holding. DGAP-News: Dermapharm Holding SE / Key word(s): Alliance 10.09.2020 / 14:53 The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine Grünwald, September 10, 2020 - Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas, will support the vaccine developer BioNTech SE in part of the vaccine production of BNT162b2 starting in the fourth quarter of 2020. Once approval for the vaccine has been received, the Dermapharm Group will make production capacities available and expand them at its German site in order to offer BioNTech the greatest possible support.
Together with the collaboration partner Pfizer, BioNTech has initiated a global Phase 2b/3 study involving the COVID-19 vaccine BNT162b2. Company profile: Dermapharm - Pharmaceutical Excellence "Made in Germany" Contacts. Avanti Polar Lipids. Knauer. In connection with the development of mRNA-based vaccines against Corona, lipid nanoparticles (LNPs) have shown to be a suitable delivery form. LNPs encapsulate and protect the delicate active ingredient and allow its transport to the target cells in the human body. This will be the first large-scale use of mRNA and lipid nanoparticles in vaccination history. KNAUER, the Berlin based manufacturer of high-tech laboratory instruments mostly known for its liquid chromatography systems, also supplies production equipment for pharmaceutical lipid nanoparticles. This development was made possible by combining the company’s expertise in high pressure dosing and in laboratory systems engineering.
New and promising developments in medicine make pharmaceuticals and their active ingredients increasingly complex and bring new challenges. Oligonucleotides, for example, are very susceptible to degradation in the human body. Acuitas. Evonik Industries. Polymun. WeylChem. CordenPharma. Sigmaaldrich. Organix Inc.